Barbara A Sullivan Selected Research

AMG 557

1/2018

Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara A Sullivan Research Topics

Disease

3	Ulcerative Colitis 07/2019 - 12/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 12/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2017
1	Rheumatoid Arthritis 10/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2022
1	Ornithine Carbamoyltransferase Deficiency Disease 03/2022
1	Arthritis (Polyarthritis) 01/2018
1	Proteinuria 01/2017
1	Discoid Lupus Erythematosus 01/2017
1	Lupus Nephritis 01/2017
1	Colitis 12/2014
1	Asthma (Bronchial Asthma) 02/2010
1	Neoplasms (Cancer) 09/2005
1	Virus Diseases (Viral Diseases) 01/2004

Drug/Important Bio-Agent (IBA)

3	abrilumabIBA 07/2019 - 12/2014
2	LigandsIBA 10/2022 - 01/2018
2	Peptides (Polypeptides)IBA 10/2022 - 01/2004
2	IntegrinsIBA 07/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2017 - 12/2014
2	AMG 811IBA 01/2017 - 01/2017
2	InterferonsIBA 01/2017 - 01/2017
1	B-Cell Activating FactorIBA 10/2022
1	rozibafusp alfaIBA 10/2022
1	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 03/2022
1	AMG 557IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Complement C3 (C3 Complement)IBA 01/2017
1	anti-dsDNA autoantibodyIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Complement C4 (Complement Component 4)IBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	DPPE-PEG2000IBA 02/2010
1	GlycolipidsIBA 09/2005
1	alpha-galactosylceramideIBA 09/2005

Therapy/Procedure

2	Therapeutics 07/2019 - 01/2019